A comprehensive understanding of this pathway will not only solve a long-standing problem in molecular cell biology, but will also pave the way for the development of new inhibitors that have great potential for cancer therapy, for example, in fighting chemoresistances that are caused by FGF2 in acute myeloid leukemia. Here, FGF2 is linked to cancer.